Tryptamine Therapeutics Ltd (ASX:TYP – Get Free Report) insider Jason Carroll acquired 1,692,514 shares of the company’s stock in a transaction dated Thursday, June 6th. The shares were bought at an average cost of A$0.02 ($0.01) per share, with a total value of A$35,542.79 ($23,538.27).
Jason Carroll also recently made the following trade(s):
- On Monday, June 3rd, Jason Carroll bought 1,000,000 shares of Tryptamine Therapeutics stock. The stock was bought at an average price of A$0.03 ($0.02) per share, with a total value of A$25,000.00 ($16,556.29).
- On Thursday, May 30th, Jason Carroll acquired 500,000 shares of Tryptamine Therapeutics stock. The shares were purchased at an average price of A$0.02 ($0.02) per share, with a total value of A$12,000.00 ($7,947.02).
Tryptamine Therapeutics Stock Performance
Featured Stories
- Five stocks we like better than Tryptamine Therapeutics
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Top 3 High-Yield Stocks with Strong Analyst Ratings
- Dividend Payout Ratio Calculator
- 3 Stocks to Watch: Chip Shortage Impact on Industries
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Dividend King ABM Industries is on Track for New Highs
Receive News & Ratings for Tryptamine Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tryptamine Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
